Weichen Lin
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Neurology top 10%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
-
- Long-Term Effects of COVID-19 3
- Co-authors
- Heng Meng (6 shared papers)Ruyuan He (6 shared papers)Wenyang Jiang (4 shared papers)Zilong Lu (5 shared papers)Xiaokang Shen (4 shared papers)Bo Hao (4 shared papers)Tao T. Fan (4 shared papers)Rui Xiong (3 shared papers)
- Journals
- Cell Death Discovery (1 paper)Journal of Cancer (1 paper)QJM (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)Journal of Clinical Virology (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Weichen Lin
10 papers receiving 779 citations
Weichen Lin's Hit Papers
Peers
Comparison fields: 5 of 96
- Infectious Diseases 321
- Neurology 133
- Cancer Research 76
- Immunology 100
- Pulmonary and Respiratory Medicine 146
Countries citing papers authored by Weichen Lin
This map shows the geographic impact of Weichen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weichen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weichen Lin more than expected).
Fields of papers citing papers by Weichen Lin
This network shows the impact of papers produced by Weichen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weichen Lin. The network helps show where Weichen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Weichen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsis-induced acute lung injury Hit paper breakdown → | 2022 | 217 |
| 2 | 2020 | 209 | |
| 3 | 2020 | 184 | |
| 4 | 2022 | 104 | |
| 5 | 2020 | 27 | |
| 6 | 2020 | 17 | |
| 7 | 2021 | 11 | |
| 8 | 2014 | 10 | |
| 9 | 2020 | 7 | |
| 10 | 2014 | 3 |
About Weichen Lin
Weichen Lin is a scholar working on Infectious Diseases, Neurology, Molecular Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 10 papers that have together received 789 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Long-Term Effects of COVID-19 (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Circular RNAs in diseases (1 paper), Ferroptosis and cancer prognosis (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Esophageal Cancer Research and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (321 citations), Neurology (133 citations), Cancer Research (76 citations), Immunology (100 citations) and Pulmonary and Respiratory Medicine (146 citations). Weichen Lin has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Heng Meng, Ruyuan He, Wenyang Jiang, Zilong Lu, Xiaokang Shen, Bo Hao, Tao T. Fan, Rui Xiong, Haojie Feng and Qing Geng. Their work appears in journals such as Cell Death Discovery, Journal of Cancer, QJM, Antimicrobial Agents and Chemotherapy and Journal of Clinical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.